Aspira Women's Health Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Aspira Women's Health Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Aspira Women's Health Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $57.2M, a 15.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $57.2M +$7.49M +15.1% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $49.7M +$7.79M +18.6% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $41.9M +$6.7M +19% Dec 31, 2021 10-K/A 2023-10-26
Q4 2020 $35.2M +$3.32M +10.4% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $31.9M +$6.44M +25.3% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $25.4M +$2.11M +9.05% Dec 31, 2018 10-K 2020-04-07
Q4 2017 $23.3M -$7.77M -25% Dec 31, 2017 10-K 2019-03-28
Q4 2016 $31.1M -$43.2M -58.1% Dec 31, 2016 10-K 2018-03-13
Q4 2015 $74.3M +$6.84M +10.1% Dec 31, 2015 10-K 2017-03-31
Q4 2014 $67.4M +$3.09M +4.79% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $64.3M +$7.05M +12.3% Dec 31, 2013 10-K 2015-03-31
Q4 2012 $57.3M +$2.09M +3.78% Dec 31, 2012 10-K 2014-03-31
Q4 2011 $55.2M Dec 31, 2011 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.